Patent · US Active

Hydroxyl purine compounds and applications thereof

USRE49128E1 · kind E1 · reissue

0Cited by
8References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 19, 2020
Grant dateJul 12, 2022
Priority date
Expiry dateFeb 19, 2040

Classification

  • Technology area (CPC —)General

Abstract

Hydroxyl purine compounds represented by formula (I), tautomers or pharmaceutically acceptable salts thereof, and applications thereof as PDE2 or TNF-α inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.